Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.

Bloss, E; Kuksa, L; Holtz, T H; Riekstina, V; Skripconoka, V; Kammerer, S; Leimane, V

Bloss, E; Kuksa, L; Holtz, T H; Riekstina, V; Skripconoka, V; Kammerer, S; Leimane, V.

Affiliation

Bloss E; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. dpu2@cdc.gov

Int J Tuberc Lung Dis ; 14(3): 275-81, 2010 Mar.

Article in En | MEDLINE | ID: mdl-20132617

Subject(s)

Antitubercular Agents/adverse effects; Tuberculosis, Multidrug-Resistant/drug therapy; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents/administration & dosage; Antitubercular Agents/therapeutic use; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Latvia/epidemiology; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Tuberculosis, Multidrug-Resistant/epidemiology; Tuberculosis, Multidrug-Resistant/physiopathology; Young Adult

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Tuberc Lung Dis Year: 2010 Document type: Article Affiliation country: United States Country of publication: France

Search on Google

Add to My VHL

XML

PubMed Links